SCHEMBL14720135

SCHEMBL14720135

CC(CN)N(c1ccccn1)c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
TAAR1 Q96RJ0 4/20 0.40
ALDH1A1 P00352 3/20 0.38
HRH1 P35367 2/20 0.38
CHRM2 P08172 2/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
DRD1 P21728 1/20 0.38
HTR2A P28223 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRK1 P41145 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNH2 Q12809 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6691477 0.80 CYP2D6 (0.51) CYP2D6CYP2C19TAAR1ALDH1A1HRH1
SCHEMBL13338372 0.78 CYP2D6 (0.47) CYP2D6CYP2C19TAAR1ALDH1A1HRH1
SCHEMBL17633995 0.76 CYP2D6 (0.40) CYP2D6CYP2C19TAAR1ALDH1A1HRH1
SCHEMBL11701431 0.75 CYP2D6 (0.44) CYP2D6CYP2C19TAAR1ALDH1A1HRH1
SCHEMBL13338416 0.72 ALDH1A1 (0.46) CYP2D6CYP2C19TAAR1ALDH1A1HRH1
SCHEMBL17070034 0.71 CYP2D6 (0.48) CYP2D6CYP2C19TAAR1ALDH1A1HRH1
SCHEMBL4971165 0.70 TAAR1 (0.52) TAAR1HRH1SLC6A2SLC6A4HTR2A
SCHEMBL1225311 0.70 CYP2D6 (0.47) CYP2D6CYP2C19TAAR1ALDH1A1HRH1
SCHEMBL4461877 0.70 SLC6A2 (0.48) CYP2D6CYP2C19ALDH1A1HRH1CHRM2
SCHEMBL11697724 0.69 ALDH1A1 (0.41) CYP2D6CYP2C19TAAR1ALDH1A1HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2744771-B1 C-HALOGEN BOND FORMATION UNIV PRINCETON (US) 2020-10-21 EP claimed
US-20200190012-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2020-06-18 US claimed
US-20140227184-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2014-08-14 US claimed
EP-2744771-A1 C-HALOGEN BOND FORMATION The Trustees of Princeton University (US) 2014-06-25 EP claimed
WO-2013028639-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-02-28 WO claimed
EP-2744771-B1 C-HALOGEN BOND FORMATION UNIV PRINCETON (US) 2020-10-21 EP disclosed
US-20200190012-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2020-06-18 US disclosed
US-20190127311-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2019-05-02 US disclosed
US-10196341-B2 C-halogen bond formation THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2019-02-05 US disclosed
US-20160264512-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-09-15 US disclosed
WO-2015054476-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2015-04-16 WO disclosed
US-20150031768-A1 C-HALOGEN BOND FORMATION NATIONAL SCIENCE FOUNDATION 2015-01-29 US disclosed
US-20140249329-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2014-09-04 US disclosed
US-20140227184-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2014-08-14 US disclosed
EP-2744771-A1 C-HALOGEN BOND FORMATION The Trustees of Princeton University (US) 2014-06-25 EP disclosed
WO-2013081685-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-06-06 WO disclosed
WO-2013028639-A1 C-HALOGEN BOND FORMATION THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190012-A1 C-HALOGEN BOND FORMATION CBR3, FOS, CBR1 CYP2D6 1756/4885CYP2C19 2559/4885TAAR1 4203/4885
US-20140227184-A1 C-HALOGEN BOND FORMATION CBR3, FOS, CBR1 CYP2D6 1756/4885CYP2C19 2559/4885TAAR1 4203/4885
US-20160264512-A1 C-HALOGEN BOND FORMATION FOS, BCL3, CBR3 CYP2D6 2159/4885CYP2C19 2701/4885TAAR1 4515/4885
US-20190127311-A1 C-HALOGEN BOND FORMATION CBR3, FOS, CBR1 CYP2D6 1756/4885CYP2C19 2559/4885TAAR1 4203/4885
US-20140249329-A1 C-HALOGEN BOND FORMATION CBR3, FOS, CBR1 CYP2D6 1756/4885CYP2C19 2559/4885TAAR1 4203/4885
US-10196341-B2 C-halogen bond formation CBR3, FOS, CBR1 CYP2D6 1756/4885CYP2C19 2559/4885TAAR1 4203/4885
US-20150031768-A1 C-HALOGEN BOND FORMATION CBR3, FOS, CBR1 CYP2D6 1756/4885CYP2C19 2559/4885TAAR1 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.